Experiment 125752

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEPATENT DESCRIBED

Compounds isolated

FUSOBACTERIUM ANTIBIOTIC TF-320

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DOSING ON DAYS 1-7.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismFusobacterium nucleatum (BACTERIOIDACEAE)
CitationTAMAI,K: SALKAWA,I: YASUDA,T: MURAKAMI,S: MAEDA,T: TSUDA,H: SAKAI,H: SUGITA,M: YAMAMOTO,Y: ET AL:. (1990). MANUFACTURE OF ANTICANCER SUBSTANCES TF-300 BY FUSOBACTERIUM NUCLEATUM AND ANTICANCER SGENTS CONTAINING THE SAME.. ()
Amount utilized
Compound isolated
Dose amount1.0 MG
Number6
Percent yield67%
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
Expression resultILS